California State Teachers Retirement System Lowers Stock Holdings in UnitedHealth Group Incorporated $UNH

California State Teachers Retirement System cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% in the 1st quarter, Holdings Channel reports. The fund owned 1,355,931 shares of the healthcare conglomerate’s stock after selling 33,063 shares during the quarter. California State Teachers Retirement System’s holdings in UnitedHealth Group were worth $366,901,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock worth $30,238,162,000 after purchasing an additional 995,210 shares during the period. State Street Corp raised its position in UnitedHealth Group by 2.5% during the 4th quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate’s stock worth $14,931,592,000 after buying an additional 1,119,834 shares during the last quarter. Capital World Investors boosted its holdings in shares of UnitedHealth Group by 3.8% in the fourth quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate’s stock valued at $7,457,723,000 after acquiring an additional 824,120 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in UnitedHealth Group by 3.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 18,829,054 shares of the healthcare conglomerate’s stock worth $6,215,660,000 after purchasing an additional 680,077 shares in the last quarter. Finally, Capital International Investors boosted its holdings in UnitedHealth Group by 6.6% in the 4th quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate’s stock valued at $6,158,734,000 after purchasing an additional 1,155,162 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on UNH shares. Oppenheimer increased their target price on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. Royal Bank Of Canada raised their target price on UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a report on Friday, July 17th. BMO Capital Markets set a $512.00 price target on shares of UnitedHealth Group in a report on Tuesday, July 21st. Cantor Fitzgerald restated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, June 11th. Finally, HSBC lifted their price target on shares of UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a research report on Monday, July 6th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $455.92.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Major Q2 earnings beat supports the rally. UnitedHealth reported adjusted earnings of $6.38 per share versus the $4.94 consensus estimate, while revenue reached $112.03 billion, above expectations of $110.81 billion. Management maintained 2026 adjusted EPS guidance of $19.50 to $20.00, reinforcing confidence in the recovery. What’s next for UnitedHealth after its major Q2 earnings beat
• Positive Sentiment: Improved medical costs and conservative guidance are encouraging investors. The company’s improved medical loss ratio helped results, and some investors view the cautious outlook as a buffer against future volatility. However, part of the margin improvement came from exiting unprofitable markets rather than broad-based operating gains. UnitedHealth Group Stock Opinions on Q2 Earnings Beat
• Positive Sentiment: The stock’s rebound after Berkshire Hathaway’s exit is being viewed favorably. Commentary noting that Berkshire likely sold too early highlights renewed investor confidence in UNH, though it does not change the company’s fundamentals. UnitedHealth Stock Has Rallied Big Since Berkshire Bailed
• Neutral Sentiment: Medicare Part D pricing creates both opportunity and risk. The planned expiration of federal subsidies could lead to higher premiums for stand-alone Medicare drug plans next year. Higher pricing may support insurers’ revenue, but it could also reduce affordability and enrollment, creating uncertainty for UnitedHealth’s Medicare business. Why Prices Could Rise for Medicare Drug Plans Next Year
• Negative Sentiment: Medicaid pressure and questions about earnings durability remain risks. Analysts have noted that market exits contributed to the better medical loss ratio, while Medicaid challenges and the stock’s rapid advance could limit additional near-term upside. UnitedHealth Pulls Back Post 52-Week High

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $428.94 on Wednesday. The company has a quick ratio of 0.80, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm’s 50-day simple moving average is $409.32 and its 200 day simple moving average is $346.72. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $461.62. The firm has a market capitalization of $389.54 billion, a PE ratio of 27.60, a P/E/G ratio of 1.45 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 19.69 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a dividend of $2.32 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. UnitedHealth Group’s payout ratio is currently 59.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.